Litcius/Paper detail

Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke

Haifeng Lu, Shujun Chen, Qianqian Nie, Qun Xue, Hua Fan, Yiqing Wang, Shenghao Fan, Juehua Zhu, Haitao Shen, Haiying Li, Qi Fang, Jianqiang Ni, Gang Chen

2023Cell Reports19 citationsDOIOpen Access PDF

Abstract

Synaptotagmin III (Syt3) is a Ca 2+ -dependent membrane-traffic protein that is highly concentrated in synaptic plasma membranes and affects synaptic plasticity by regulating post-synaptic receptor endocytosis. Here, we show that Syt3 is upregulated in the penumbra after ischemia/reperfusion (I/R) injury. Knockdown of Syt3 protects against I/R injury, promotes recovery of motor function, and inhibits cognitive decline. Overexpression of Syt3 exerts the opposite effects. Mechanistically, I/R injury augments Syt3-GluA2 interactions, decreases GluA2 surface expression, and promotes the formation of Ca 2+ -permeable AMPA receptors (CP-AMPARs). Using a CP-AMPAR antagonist or dissociating the Syt3-GluA2 complex via TAT-GluA2-3Y peptide promotes recovery from neurological impairments and improves cognitive function. Furthermore, Syt3 knockout mice are resistant to cerebral ischemia because they show high-level expression of surface GluA2 and low-level expression of CP-AMPARs after I/R. Our results indicate that Syt3-GluA2 interactions, which regulate the formation of CP-AMPARs, may be a therapeutic target for ischemic insults.

Topics & Concepts

AMPA receptorPenumbraDownregulation and upregulationCell biologyNeuroscienceSynaptotagmin 1Synaptic plasticitySNARE complexChemistryGlutamate receptorReceptorIschemiaBiologyMedicineInternal medicineMembraneSynaptic vesicleBiochemistryExocytosisVesicleGeneNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration MechanismsSleep and Wakefulness Research